RSV prevention in infants
Nirsevimab, maternal vaccination and other ways to protect infants from RSV.
Key point
A complementary, progressive strategy should integrate maternal vaccination and monoclonal antibody immunoprophylaxis, initially prioritizing high-risk infants and gradually expanding to all susceptible infants.
From: Position statement of the Mexican Academy of Pediatrics regarding strategies to prevent respiratory syncytial virus infection in Mexico's pediatric population (Bol Med Hosp Infant Mex, 2026) ↗Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 7, 10, 19, 20, 19.
New guidelines and consensus this year
- IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal RSV Infections in Immunocompromised PatientsClin Infect Dis2026 Aug 24
- IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised PatientsClin Infect Dis2026 Aug 24
- Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2025) and Update on Immunization for Children Aged 0 Through 18 YearsIndian Pediatr2026 May
- Position statement of the Mexican Academy of Pediatrics regarding strategies to prevent respiratory syncytial virus infection in Mexico's pediatric populationBol Med Hosp Infant Mex2026
- Vaccination and immunization schedule of the Pediatric Spanish Association: 2026 recommendationsAn Pediatr (Engl Ed)2026 Jan
All papers from the last 12 months
622 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- 5C psychological antecedents of vaccine hesitancy toward maternal RSV vaccines and infant monoclonal antibodies among pregnant and postpartum women and their partners in China: A multicenter, dyadic survey design, cross-sectional studyHum Vaccin Immunother2026 Dec 31PMID 42714313
- RSV vaccine uptake among Medicare Advantage enrollees: August 2023 to December 2024Hum Vaccin Immunother2026 DecPMID 42872881
- Safety of nirsevimab in children aged 0-24 months: Analysis based on EudraVigilance data (2023-2025)Hum Vaccin Immunother2026 DecPMID 42851207
- Nirsevimab for respiratory syncytial virus prevention: A comprehensive product reviewHum Vaccin Immunother2026 DecPMID 42690154Review
- Advancing human metapneumovirus vaccine development through fusion protein stabilizationVirology2026 DecPMID 42566836Review
- Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infantsHum Vaccin Immunother2026 DecPMID 42520176
- RSV prophylactics for pediatric populations: A product review and meta-analysis of real-world effectivenessHum Vaccin Immunother2026 DecPMID 42348792Meta-analysisReview
- Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreFExpert Rev Vaccines2026 DecPMID 42334170
- Acceptance of the respiratory syncytial virus infant monoclonal antibody nirsevimab among post-partum women in ItalyHum Vaccin Immunother2026 DecPMID 42268596
- Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for maternal vaccination in Sweden: cost-effectiveness and budget impactJ Med Econ2026 DecPMID 42258348
More pediatrics trends
All specialties →Genomic newborn screening
Genome or exome sequencing of newborns to detect treatable conditions.
Early autism detection
Screening and early diagnosis of autism in young children.
Kangaroo mother care
Skin-to-skin contact for preterm and low birth weight infants.
Food allergy immunotherapy
Oral immunotherapy and biologics for food allergy.
Spinal muscular atrophy therapies
Gene therapy and other disease-modifying treatments for SMA.
Social media and youth mental health
Screen time and social media use and their links to anxiety and depression in young people.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
nirsevimab[tiab] OR ("respiratory syncytial virus"[tiab] AND (vaccin*[tiab] OR "monoclonal antibod*"[tiab]) AND (infant*[tiab] OR child*[tiab]))Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.